Literature DB >> 34888646

Canine DUXC: implications for DUX4 retrotransposition and preclinical models of FSHD.

Chao-Jen Wong1, Jennifer L Whiddon1, Ashlee T Langford2, Andrea E Belleville3, Stephen J Tapscott1,4.   

Abstract

Mis-expression of DUX4 in skeletal muscle causes facioscapulohumeral muscular dystrophy (FSHD). Human DUX4 and mouse Dux are retrogenes derived from retrotransposition of the mRNA from the parental DUXC gene. Primates and rodents have lost the parental DUXC gene, and it is unknown whether DUXC had a similar role in driving an early pluripotent transcriptional program. Dogs and other Laurasiatherians have retained DUXC, providing an opportunity to determine the functional similarity to the retrotransposed DUX4 and Dux. Here, we identify the expression of two isoforms of DUXC mRNA in canine testis tissues: one encoding the canonical double homeodomain protein (DUXC), similar to DUX4/Dux, and a second that includes an in-frame alternative exon that disrupts the conserved amino acid sequence of the first homeodomain (DUXC-ALT). The expression of DUXC in canine cells induces a pluripotent program similar to DUX4 and Dux and induces the expression of a similar set of retrotransposons of the ERV/MaLR and LINE-1 families, as well as pericentromeric satellite repeats; whereas DUXC-ALT did not robustly activate gene expression in these assays. Important for preclinical models of FSHD, human DUX4 and canine DUXC show higher conservation of their homeodomains and corresponding binding motifs compared with the conservation between human DUX4 and mouse Dux, and human DUX4 activates a highly similar transcriptional program in canine cells. Together, these findings show that retrotransposition resulted in the loss of an alternatively spliced isoform and that DUXC containing mammals might be good candidates for certain preclinical models ofFSHD.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34888646      PMCID: PMC9122657          DOI: 10.1093/hmg/ddab352

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   5.121


  31 in total

Review 1.  Bioconductor: an open source framework for bioinformatics and computational biology.

Authors:  Mark Reimers; Vincent J Carey
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

2.  Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells.

Authors:  Sujatha Jagannathan; Sean C Shadle; Rebecca Resnick; Lauren Snider; Rabi N Tawil; Silvère M van der Maarel; Robert K Bradley; Stephen J Tapscott
Journal:  Hum Mol Genet       Date:  2016-10-15       Impact factor: 6.150

3.  DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo.

Authors:  Lindsay M Wallace; Sara E Garwick; Wenyan Mei; Alexandra Belayew; Frederique Coppee; Katherine J Ladner; Denis Guttridge; Jing Yang; Scott Q Harper
Journal:  Ann Neurol       Date:  2010-12-08       Impact factor: 10.422

4.  DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy.

Authors:  Linda N Geng; Zizhen Yao; Lauren Snider; Abraham P Fong; Jennifer N Cech; Janet M Young; Silvere M van der Maarel; Walter L Ruzzo; Robert C Gentleman; Rabi Tawil; Stephen J Tapscott
Journal:  Dev Cell       Date:  2011-12-29       Impact factor: 12.270

5.  AAV-mediated follistatin gene therapy improves functional outcomes in the TIC-DUX4 mouse model of FSHD.

Authors:  Carlee R Giesige; Lindsay M Wallace; Kristin N Heller; Jocelyn O Eidahl; Nizar Y Saad; Allison M Fowler; Nettie K Pyne; Mustafa Al-Kharsan; Afrooz Rashnonejad; Gholamhossein Amini Chermahini; Jacqueline S Domire; Diana Mukweyi; Sara E Garwick-Coppens; Susan M Guckes; K John McLaughlin; Kathrin Meyer; Louise R Rodino-Klapac; Scott Q Harper
Journal:  JCI Insight       Date:  2018-11-15

6.  Expression of the human FSHD-linked DUX4 gene induces neurogenesis during differentiation of murine embryonic stem cells.

Authors:  Abhijit Dandapat; Lynn M Hartweck; Darko Bosnakovski; Michael Kyba
Journal:  Stem Cells Dev       Date:  2013-05-09       Impact factor: 3.272

7.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.

Authors:  Michael I Love; Wolfgang Huber; Simon Anders
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

8.  Muscle pathology from stochastic low level DUX4 expression in an FSHD mouse model.

Authors:  Darko Bosnakovski; Sunny S K Chan; Olivia O Recht; Lynn M Hartweck; Collin J Gustafson; Laura L Athman; Dawn A Lowe; Michael Kyba
Journal:  Nat Commun       Date:  2017-09-15       Impact factor: 14.919

9.  Transgenic mice expressing tunable levels of DUX4 develop characteristic facioscapulohumeral muscular dystrophy-like pathophysiology ranging in severity.

Authors:  Takako I Jones; Guo-Liang Chew; Pamela Barraza-Flores; Spencer Schreier; Monique Ramirez; Ryan D Wuebbles; Dean J Burkin; Robert K Bradley; Peter L Jones
Journal:  Skelet Muscle       Date:  2020-04-11       Impact factor: 4.912

10.  DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes.

Authors:  Si Ho Choi; Micah D Gearhart; Ziyou Cui; Darko Bosnakovski; Minjee Kim; Natalie Schennum; Michael Kyba
Journal:  Nucleic Acids Res       Date:  2016-03-06       Impact factor: 16.971

View more
  1 in total

Review 1.  The evolution of DUX4 gene regulation and its implication for facioscapulohumeral muscular dystrophy.

Authors:  Sujatha Jagannathan
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2022-02-11       Impact factor: 6.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.